COP CompuGroup Medical SE & Co. KGaA

DGAP-News: CompuGroup Medical reports record results at virtual Annual General Meeting and confirms growth targets

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): AGM/EGM
CompuGroup Medical reports record results at virtual Annual General Meeting and confirms growth targets

19.05.2022 / 13:42
The issuer is solely responsible for the content of this announcement.


Koblenz. CompuGroup Medical SE & Co. KGaA, one of the world's leading e-health companies, held its Annual General Meeting today, once again in a virtual setting. All agenda items were approved by a majority. Management also confirmed the guidance for the current year and medium-term growth targets.

The attendees at the Annual General Meeting, which was once again held virtually, represented around 81 % of CompuGroup Medical’s capital stock. The resolutions on the appropriation of profits and the proposed dividend of EUR 0.50 were approved with a majority of 99.9 %. The Annual General Meeting also approved, with clear majorities of more than 75 % of the votes respectively, the resolutions on the discharge of the General Partner and the Supervisory Board, on the appointment of the auditors, and on an amendment to the Articles of Association, which are intended to allow for greater flexibility in choosing venues for future Annual General Meetings. The resolutions on the compensation report and compensation system for the Managing Directors were also approved with around 75 % more than 69 % of the votes respectively.

In his speech, CEO Dirk Wössner highlighted several examples as to how digitization can make healthcare not only more user-friendly, efficient and effective, but also safer. According to the CEO, solutions that are more user-friendly, more efficient, more effective and, on top of that, safer, generally win through. The healthcare sector is therefore in a state of upheaval worldwide and the e-health sector is a huge growth market with CompuGroup Medical as one of the most important players. This also illustrates the growth potential of the company.

"We have significantly accelerated our organic growth and at the same time decisively strengthened it through strategic acquisitions," said Wössner, summing up the recipe of success in the past fiscal year. "It was an outstanding year of growth for us. We achieved the targets we had set ourselves for 2021, in particular significant revenue growth and very promising organic growth. We exceeded 1,000 million euros in revenue for the first time last year. At 22 percent, revenue growth was almost twice as high as in 2020. And operating profit also rose again: By more than 4 percent to 224 million." And, he emphasized, "we have once again set a revenue record."

Michael Rauch, CFO of CompuGroup Medical, was also satisfied with the results of the past financial year as reflected in his comments: " Free cash flow, which was already very good in the 2020 financial year, was elevated again in the past financial year and exceeded the EUR 100 million threshold for the first time in the history of CompuGroup Medical." And further: "In recent years, we have managed to improve both revenue growth and the quality of revenues generated, reflected in the increased share of recurring revenues, to a new level."

In his speech, CEO Dr. Dirk Wössner accordingly confirmed the guidance for the current fiscal year: "We again expect significant organic growth of 3 to 8 percent in 2022. We are on course for consolidated revenue of more than EUR 1.1 billion. We see adjusted EBITDA at 235 to 260 million euros, corresponding to an adjusted EBITDA margin of between 21 and 24 percent. Our economic course is clearly set on achieving success and growth."

Information on the Annual General Meeting, including the complete voting results, is available at .

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.025 billion in 2021, its software products are designed to support all medical and organizational activities in doctors’ offices, pharmacies, laboratories, hospitals and social institutions. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical’s services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 19 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 8,500 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Contact for Media Representatives:
Alexander Weimer
Head of Corporate Communications
P 00
E-mail:

Contact for analysts and investors:
Claudia Thomé
Corporate Vice President Investor Relations
P
E-mail:



19.05.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)160 3630362
Fax: +49 (0)261 8000 3200
E-mail:
Internet:
ISIN: DE000A288904
WKN: A28890
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1356971

 
End of News DGAP News Service

1356971  19.05.2022 

fncls.ssp?fn=show_t_gif&application_id=1356971&application_name=news&site_id=research_pool
EN
19/05/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CompuGroup Medical SE & Co. KGaA

 PRESS RELEASE

EQS-News: CompuGroup Medical USA kündigt Staffelstabübergabe in der CE...

EQS-News: CompuGroup Medical SE & Co. KGaA / Schlagwort(e): Personalie CompuGroup Medical USA kündigt Staffelstabübergabe in der CEO-Position des US-Geschäfts an 25.03.2024 / 12:32 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CompuGroup Medical USA kündigt Staffelstabübergabe in der CEO-Position des US-Geschäfts an   Austin, Texas – CompuGroup Medical (CGM) ernennt Benedikt Brueckle mit Wirkung zum 1. Januar 2025 zum neuen Chief Executive Officer für die USA. Damit kommt es zur Staffelstabübergabe in der Führung des US-Geschäft...

 PRESS RELEASE

EQS-News: CompuGroup Medical US announces CEO transition

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Personnel CompuGroup Medical US announces CEO transition 25.03.2024 / 12:32 CET/CEST The issuer is solely responsible for the content of this announcement. CompuGroup Medical US announces CEO transition   Austin, TX – Underlining the commitment to its second largest market worldwide by revenue, CompuGroup Medical announces the appointment of Benedikt Brueckle as its new Chief Executive Officer for the US, effective January 1, 2025. Benedikt Brueckle is a respected and experienced leader in the healthcare IT indus...

 PRESS RELEASE

EQS-News: CGM plans to double its dividend

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Dividend CGM plans to double its dividend 20.02.2024 / 20:37 CET/CEST The issuer is solely responsible for the content of this announcement. CGM plans to double its dividend Koblenz. The general partner of CompuGroup Medical SE & Co. KGaA (CGM) intends to sustainably increase the dividend to a higher level, and will therefore propose a dividend of EUR 1.00 per share to the Annual General Meeting for the financial year 2023. Based on the 52.2 million shares currently entitled to a dividend payment, the planned tota...

 PRESS RELEASE

EQS-News: CGM plant Verdopplung der Dividende

EQS-News: CompuGroup Medical SE & Co. KGaA / Schlagwort(e): Dividende CGM plant Verdopplung der Dividende 20.02.2024 / 20:37 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CGM plant Verdopplung der Dividende Koblenz. Die persönlich haftende Gesellschafterin der CompuGroup Medical SE & Co. KGaA (CGM) beabsichtigt, die Dividende nachhaltig auf ein höheres Niveau anzuheben. Sie plant daher, der Hauptversammlung für das Geschäftsjahr 2023 eine Dividende von 1,00 Euro je Aktie vorzuschlagen. Basierend auf aktuell 52,2 Millionen dividend...

Oliver Metzger
  • Oliver Metzger

ODDO BHF Small & MIDCAP MORNING NEWS - 02/15/2024

GALP, TotalEnergies and Shell have discovered vast oil deposits off the coast of Namibia. Oil services companies see this as a new Eldorado. FPSO-type solutions seem to be favoured, making SBM Offshore a key player, not forgetting subsea companies such as TechnipFMC. The whole sector could help local economic development... and/or have major negative impacts on local communities, biodiversity or the fight against corruption. Not to mention the carbon lock-in. We would therefore urge i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch